April 25, 2019 -- Medican Limited, the parent company of MCan Coin, has managed to create awareness, interest, and solutions for chronic diseases like cancer, epilepsy, PTSD and so on. In addition, the company ensured the medical community accepts that pharmaceutical-grade cannabis products plays a key role in providing organic, cost-effective and potentially disruptive solution to the perennial problem for millions of people across the world.

“This is an exciting time for the medical cannabis industry. There is legalization in many states and countries across the globe, giving investors returns much higher than expected and research on cannabis is the topic for medical innovation,” said Chandra Sekar, Chairman, Medican Ltd.

Cannabis-related businesses are one of the fastest growing industries, of which the medical marijuana market alone was worth $8.28 Billion in 2017 and is expected to grow to $140 billion in the next decade. With the future in mind, Medican Ltd is on the path to achieving the milestones mentioned in the roadmap, thereby, enhancing token-holder value with an aim to reach 10x growth in the next 5-7 years.

“Medican Ltd is positioned for growth, profitability and token-holder returns. We aim to drive forward and accelerate the growth of the company through strategic partnerships and aggressively moving into 13 countries by the end of 2020. We are keen to be known as an innovating company acting as game-changer for the industry” added Chandra Sekar, Chairman, Medican Ltd.

Using the power of Blockchain, and community strength of LAToken & IDAX, MCan Coin is going to disrupt the Medical Cannabis and Healthcare industry while changing the way we see ICOs in the future.

Contact:
Kesavan Rajaram
Blockchain App Factory
Singapore
+13235224739
[email protected]
https://www.blockchainappfactory.com